Gulliver's travels in HIVland

Nature

Volumn 410, Issue 6831, 2001, Pages 963-967

  Weiss, R A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; DISEASES; IMMUNIZATION;

VIRUCIDAL LOTIONS;

VIRUSES;

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIGEN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTATION; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNIZATION; MEDICAL ETHICS; MOLECULAR EVOLUTION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

AIDS VACCINES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTI-HIV AGENTS; CLINICAL TRIALS; DISEASE OUTBREAKS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNIZATION PROGRAMS; INFECTION; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035912248     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35073632     Document Type: Review

References (53)

1. The global impact of HIV/AIDS
2. + T-cell depletion in HIV disease
3. Cellular immune responses to HIV
4. HIV chemotherapy
5. Challenges and opportunities for development of an AIDS vaccine
6. Pathways to neuronal injury and apoptosis in HIV-associated dementia
7. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men in New York City and California
8. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS
9. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
10. Polio vaccine samples not linked to AIDS
11. Analysis of oral polio vaccine CHAT stocks
12. Why don't the natural hosts of SIV develop simian AIDS?
13. The role of HIV gp120 in the disruption of the immune system
14. HIV-2-infected patients survive longer than HIV-1-infected patients
15. The mortality and pathology of HIV infection in a west African city
16. Serial human passage of SIV unsterile injecting and the emergence of epidemic HIV in Africa
17. Timing the ancestor of the HIV-1 pandemic strains
18. Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes
19. HIV-1 sequence variation, drift, shift, and attenuation
20. Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon
21. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient
22. Are RNA viruses adapting or merely changing?
23. Change in tropism upon immune escape by human immunodeficiency virus
24. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
25. The making of HIV epidemics: What are the driving forces?
26. Male circumcision and risk of HIV infection in sub-Saharan Africa: A systematic review and meta-analysis
27. How does male circumcision protect against HIV infection?
28. Vaginal microbicides for the prevention of HIV/AIDS: Assessment of the potential market
29. Microbicides in HIV prevention
30. Low-efficacy HIV vaccines: Potential for community-based intervention programmes
31. Infectious history
32. Durban Declaration
33. The natural history of HIV-1 infection in Africa
34. Sexually transmitted retribution
35. Streptococcus pneumoniae blood culture isolates from patients with and without HIV infection: Alterations in penicillin susceptibilities and in serogroups or serotypes
36. 23-Valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: Double-blind, randomised and placebo controlled trial
37. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in a child with HIV infection in Zimbabwe
38. Stopping poliovirus vaccination after eradication: Issues and challenges
39. Implications of the human immunodeficiency virus epidemic for control and eradication of measles
40. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS
41. Fungal infections in the immunocompromised
42. Pathogenicity islands and the evolution of microbes